US (PA): $57M acquisition of a Pennsylvania-based MMJ cultivation and processing facility

Ayr Strategies has moved to a Definitive Merger Agreement from Letter of Intent with CannTech.

Ayr intends to purchase 100% of the membership interests of CannTech PA for total purchase consideration of US$57 million, which will be paid as to US$27 million in cash, US$15 million in exchangeable shares, each of which would be exchangeable for a subordinate voting share, and US$15 million in seller’s notes.

CannTech is a licensed operator in the Commonwealth of Pennsylvania including a 143,000 ft² cultivation and processing facility under development, with the initial construction phase comprising 45,000 ft² recently approved for cultivation and with an expected first harvest in March 2021. "The 13-acre site provides ample room for further expansion beyond the existing 143,000 ft² facility," Ayr team explains. "The licensed operator also has the right to operate six dispensaries poised to open in excellent retail locations, most of which are clustered in the Pittsburgh and Philadelphia regions. The first dispensary opened last month in New Castle, PA, with two more expected to open in early 2021. The licensed operator also has a strong research program in collaboration with a local medical school. The transaction is expected to close by year-end, subject to customary conditions including required regulatory approvals."

For more information:
Ayr Strategies
ir.ayr.inc


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


© MMJDaily.com 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber